Start your Trading & Investing Journey with us
Join our channel for Daily Free Trades with Live analysis on Youtube, Trade Setup with Important Levels, and Important Stock Market Updates
Corona Remedies IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details
Corona Remedies Limited IPO : Key Performance Indicators, PE Ratio, EPS, ROE, ROCE & RoNW
The Company Key Performance Indicates the pre-issue EPS of ₹24.43 and post-issue EPS of ₹24.43 for FY25. The pre-issue P/E ratio is 43.47x,while the post-issue P/E ratio is 43.47x against the Industry P/E ratio is 43.74x The company's ROE for FY25 is 27.50% and RoNW is 24.65% The Annualised EPS is ₹30.21x and P/E is 35.15x. These metrics suggest that the IPO is Fairly priced.
Key Performance Indicator
| KPI | Values |
|---|---|
| EPS Pre IPO (Rs.) | 24.43 |
| EPS Post IPO (Rs.) | 24.43 |
| Adjusted 12M EPS Post IPO (Rs.) | 30.21 |
| P/E Pre IPO | 43.47 |
| P/E Post IPO | 43.47 |
| Adjusted 12M P/E Post IPO | 35.15 |
| ROE | 27.50% |
| ROCE | 41.32% |
| P/BV | 10.71 |
| Debt/Equity | 0.1 |
| RoNW | 24.65% |
| EBITDA Margin | 20.55% |
| PAT Margin | 12.43% |
© 2022 CA Abhay Varn. All Rights Reserved Abhayvarn.com
